As there is already information about abnormalities in autonomic and enteric nervous systems, cardiovascular system, and pancreas in SMA patients, allowing the expression of SMN gene in these tissues can be favorable. This evidence concerns the gene SMN2 and proximal spinal muscular atrophy.